Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free ... their previous forecast of ($1.33). HC Wainwright has a “Buy” rating and a $50.00 price objective on the stock.

Belghiti now expects that the biopharmaceutical company will post earnings of ($2.74) per share for the quarter, up from their previous forecast ... Shares of CRBP stock opened at $6.79 on Friday.

Fintel reports that on February 28, 2025, William Blair initiated coverage of Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) with a Outperform recommendation. Analyst Price Forecast Suggests 690. ...

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has reached a 52-week low, trading at $7.87, with InvestingPro data showing the stock is currently trading below its Fair... In a recent ...

Investors in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 17, ...

March 11, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus” or the "Company ... increase was primarily attributable to product development and stock-based ...

Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the Earnings Calendar to see dates for upcoming earnings announcements.

Corbus Pharmaceuticals (CRBP) could be a solid choice for investors ... which is one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's ...